Company Information
- Type:
- Company
- Country:
- Türkiye
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Delisted
- Reason for Delisting:
- Participant requested withdrawal
- Participant Since
- 30 April 2010 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 10 August 2022
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 10-Aug-2021 | Communication on Progress | Active |
| 11-Nov-2019 | Communication on Progress | Active |
| 14-Nov-2018 | Communication on Progress | Active |
| 15-Aug-2018 | Grace Letter | Not applicable |
| 16-Aug-2017 | Bilim Pharmaceuticals CR Report | Active |
| 17-Aug-2016 | Communication on Progress | Active |
| 17-Aug-2015 | Communication on Progress | Active |
| 10-Mar-2014 | 2012 Communication on Progress | Active |
| 04-Sep-2013 | Grace Letter | Not applicable |
| 03-Sep-2012 | Bilim 2011 Communication on Progress Report | Active |
| 29-Jun-2012 | Grace Letter | Not applicable |
| 29-Jun-2011 | 2011 Communication on Progress | Active |
| 04-May-2011 | Grace Letter | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.